Although a small-scale study has reported that adjuvant chemotherapy with UFT in patients with EGFR mutation had no effect on survival prolongation [12,13], the therapeutic efficacy of UFT in lung cancer with EGFR mutations has not been fully elucidated in large-scale studies. The gene discussed is EGFR; the disease is lung cancer.